February 14, 2017 / 1:28 PM / 5 months ago

BRIEF-Aequus expects to report topline results from multi-dose study in Q1

1 Min Read

Feb 14 (Reuters) - Aequus Pharmaceuticals Inc :

* Aequus successfully completes dosing in second proof of concept clinical trial of transdermal aripiprazole patch

* Aequus Pharmaceuticals Inc- company expects to report topline results from multi-dose study in Q1 of 2017 for AQS1301 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below